Method of predicting Diabetic Foot Ulcer Recurrence or Prognostics using Specific Methylation of gene

摘要

The present invention relates to a biomarker for predicting diabetic foot ulcer recurrence or prognosis according to specific methylation of one or more genes selected from the group consisting of MORN1 , NCOR2 , and LINC00504 . The present invention identifies a specific pattern of diabetic foot ulcer recurrence or prognosis, discovers major biomarkers that explain the pattern through machine learning for genetic data, and uses the blood analysis-based clinical biomarker for diabetic foot Not only can it predict ulcer recurrence or prognosis, but it can also be used for the development of mechanisms for preventing or treating diabetic foot ulcers in the future. It is possible to build a system that can preemptively control.